Amarin Corp Plcuk (AMRN) Gains from Sales and Divestitures (2013 - 2025)

Amarin Corp Plcuk (AMRN) posted quarterly Gains from Sales and Divestitures of $8.5 million for Q4 2025, up 121.78% YoY from $3.9 million in Q4 2024, and up 121.78% sequentially from $3.9 million in Q4 2024.

Amarin Corp Plcuk (AMRN) Gains from Sales and Divestitures (2013 - 2025) Analysis & Trends

Amarin Corp Plcuk has disclosed Gains from Sales and Divestitures across 12 years of filings, most recently posting $8.5 million for Q4 2025.

  • In Q4 2025, Gains from Sales and Divestitures rose 121.78% year-over-year to $8.5 million; the TTM figure through Dec 2025 stood at $8.5 million (up 121.78% YoY), while the FY2025 annual figure was $8.5 million, up 121.78% from the prior year.
  • Gains from Sales and Divestitures climbed to $8.5 million in Q4 2025, from $3.9 million in the prior quarter.
  • Over the last five years, Gains from Sales and Divestitures for AMRN reached as high as $8.5 million in Q4 2025 and fell as low as $1.9 million in Q4 2022.
  • The 5-year median for Gains from Sales and Divestitures is $4.1 million (2021), against an average of $4.5 million.
  • Annual changes were most pronounced in 2022 — Gains from Sales and Divestitures tumbled 52.18% — and 2025, when it jumped 121.78%.
  • A 5-year view of Gains from Sales and Divestitures shows it stood at $4.1 million in 2021, then plunged by 52.18% to $1.9 million in 2022, then soared by 119.02% to $4.2 million in 2023, then slipped by 9.34% to $3.9 million in 2024, then soared by 121.78% to $8.5 million in 2025.
  • According to Business Quant data, Gains from Sales and Divestitures over the past three periods registered $8.5 million, $3.9 million, and $4.2 million for Q4 2025, Q4 2024, and Q4 2023 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,066.16 Bn 1,060.88 Bn 16.22 Bn
2 Johnson & Johnson 611.69 Bn 589.64 Bn 15.96 Bn
3 AbbVie 444.34 Bn 434.99 Bn 10.78 Bn
4 Astrazeneca 284.94 Bn 277.05 Bn 12.61 Bn
5 Merck 224.23 Bn 218.58 Bn 12.09 Bn
6 Amgen 195.12 Bn 183.08 Bn 5.87 Bn
7 Gilead Sciences 156.45 Bn 148.73 Bn 5.52 Bn
8 Pfizer 136.01 Bn 123.24 Bn -1.21 Bn
9 Novartis Ag 113.45 Bn 113.67 Bn -
10 Amarin Corp Plcuk 5.17 Bn 5.00 Bn 17.77 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 8.54 Mn
Dec 31, 2025 8.54 Mn
Dec 31, 2024 3.85 Mn
Dec 31, 2024 3.85 Mn
Dec 31, 2023 4.25 Mn
Dec 31, 2023 4.25 Mn
Dec 31, 2022 1.94 Mn
Dec 31, 2022 1.94 Mn
Dec 31, 2021 4.06 Mn
Dec 31, 2021 4.06 Mn
Dec 31, 2020 2.51 Mn
Dec 31, 2020 2.51 Mn
Dec 31, 2019 3.97 Mn
Dec 31, 2019 3.97 Mn
Dec 31, 2018 4.61 Mn
Dec 31, 2018 4.61 Mn
Dec 31, 2017 2.18 Mn
Dec 31, 2017 2.18 Mn
Dec 31, 2016 1.85 Mn
Dec 31, 2016 1.85 Mn